Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression

Summary: Whole exome sequencing was performed in a patient with myelodysplastic syndrome before and after progression to acute myeloid leukaemia. Mutations in several genes, including SETBP1, were identified following leukaemic transformation. Screening of 328 patients with myeloid disorders reveale...

Full description

Bibliographic Details
Main Authors: Fernandez-Mercado, M, Pellagatti, A, Di Genua, C, Larrayoz, M, Winkelmann, N, Aranaz, P, Burns, A, Schuh, A, Calasanz, M, Cross, N, Boultwood, J
Format: Journal article
Language:English
Published: 2013
_version_ 1826306618793394176
author Fernandez-Mercado, M
Pellagatti, A
Di Genua, C
Larrayoz, M
Winkelmann, N
Aranaz, P
Burns, A
Schuh, A
Calasanz, M
Cross, N
Boultwood, J
author_facet Fernandez-Mercado, M
Pellagatti, A
Di Genua, C
Larrayoz, M
Winkelmann, N
Aranaz, P
Burns, A
Schuh, A
Calasanz, M
Cross, N
Boultwood, J
author_sort Fernandez-Mercado, M
collection OXFORD
description Summary: Whole exome sequencing was performed in a patient with myelodysplastic syndrome before and after progression to acute myeloid leukaemia. Mutations in several genes, including SETBP1, were identified following leukaemic transformation. Screening of 328 patients with myeloid disorders revealed SETBP1 mutations in 14 patients (4·3%), 7 of whom had -7/del(7q) and 3 had i(17)(q10), cytogenetic markers associated with shortened overall survival and increased risk of leukaemic evolution. SETBP1 mutations were frequently acquired at the time of leukaemic evolution, coinciding with increase of leukaemic blasts. These data suggest that SETBP1 mutations may play a role in MDS and chronic myelomonocytic leukaemia disease progression. © 2013 John Wiley and Sons Ltd.
first_indexed 2024-03-07T06:50:42Z
format Journal article
id oxford-uuid:fc74f7aa-b96b-41e0-ab6a-15a55f158085
institution University of Oxford
language English
last_indexed 2024-03-07T06:50:42Z
publishDate 2013
record_format dspace
spelling oxford-uuid:fc74f7aa-b96b-41e0-ab6a-15a55f1580852022-03-27T13:20:55ZMutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progressionJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:fc74f7aa-b96b-41e0-ab6a-15a55f158085EnglishSymplectic Elements at Oxford2013Fernandez-Mercado, MPellagatti, ADi Genua, CLarrayoz, MWinkelmann, NAranaz, PBurns, ASchuh, ACalasanz, MCross, NBoultwood, JSummary: Whole exome sequencing was performed in a patient with myelodysplastic syndrome before and after progression to acute myeloid leukaemia. Mutations in several genes, including SETBP1, were identified following leukaemic transformation. Screening of 328 patients with myeloid disorders revealed SETBP1 mutations in 14 patients (4·3%), 7 of whom had -7/del(7q) and 3 had i(17)(q10), cytogenetic markers associated with shortened overall survival and increased risk of leukaemic evolution. SETBP1 mutations were frequently acquired at the time of leukaemic evolution, coinciding with increase of leukaemic blasts. These data suggest that SETBP1 mutations may play a role in MDS and chronic myelomonocytic leukaemia disease progression. © 2013 John Wiley and Sons Ltd.
spellingShingle Fernandez-Mercado, M
Pellagatti, A
Di Genua, C
Larrayoz, M
Winkelmann, N
Aranaz, P
Burns, A
Schuh, A
Calasanz, M
Cross, N
Boultwood, J
Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression
title Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression
title_full Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression
title_fullStr Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression
title_full_unstemmed Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression
title_short Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression
title_sort mutations in setbp1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression
work_keys_str_mv AT fernandezmercadom mutationsinsetbp1arerecurrentinmyelodysplasticsyndromesandoftencoexistwithcytogeneticmarkersassociatedwithdiseaseprogression
AT pellagattia mutationsinsetbp1arerecurrentinmyelodysplasticsyndromesandoftencoexistwithcytogeneticmarkersassociatedwithdiseaseprogression
AT digenuac mutationsinsetbp1arerecurrentinmyelodysplasticsyndromesandoftencoexistwithcytogeneticmarkersassociatedwithdiseaseprogression
AT larrayozm mutationsinsetbp1arerecurrentinmyelodysplasticsyndromesandoftencoexistwithcytogeneticmarkersassociatedwithdiseaseprogression
AT winkelmannn mutationsinsetbp1arerecurrentinmyelodysplasticsyndromesandoftencoexistwithcytogeneticmarkersassociatedwithdiseaseprogression
AT aranazp mutationsinsetbp1arerecurrentinmyelodysplasticsyndromesandoftencoexistwithcytogeneticmarkersassociatedwithdiseaseprogression
AT burnsa mutationsinsetbp1arerecurrentinmyelodysplasticsyndromesandoftencoexistwithcytogeneticmarkersassociatedwithdiseaseprogression
AT schuha mutationsinsetbp1arerecurrentinmyelodysplasticsyndromesandoftencoexistwithcytogeneticmarkersassociatedwithdiseaseprogression
AT calasanzm mutationsinsetbp1arerecurrentinmyelodysplasticsyndromesandoftencoexistwithcytogeneticmarkersassociatedwithdiseaseprogression
AT crossn mutationsinsetbp1arerecurrentinmyelodysplasticsyndromesandoftencoexistwithcytogeneticmarkersassociatedwithdiseaseprogression
AT boultwoodj mutationsinsetbp1arerecurrentinmyelodysplasticsyndromesandoftencoexistwithcytogeneticmarkersassociatedwithdiseaseprogression